T1	intervention 28 38	Carvedilol
T2	total-participants 426 428	91
T3	intervention-participants 565 567	46
T4	control 572 579	placebo
T5	control-participants 585 587	45
T12	outcome 1621 1655	left ventricular ejection fraction
T13	outcome 1814 1866	left ventricular end systolic volume and LA diameter
T14	outcome 1980 2031	pulmonary venous peak atrial reversal flow velocity
T15	outcome 2122 2190	mitral annuli early diastolic (e') and peak systolic (s') velocities
T16	outcome 2225 2271	E (the peak early diastolic velocity)/e' ratio
T17	outcome 2435 2444	TnI level
